NCT04738708

Telegenetics or In-Person Genetic Counselling

Telegenetics or In-Person Genetic Counselling: A Comparison of Clinical Outcomes and Cost

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 150 (estimated)
• Sponsor: National Cancer Centre, Singapore · Academic / Other
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

This study aims to compare clinical outcomes (informed choice and genetic counselling outcomes) and cost (provider and patient time, travel, and telehealth platform) between telegenetics and in-person genetic counselling.

Detailed description

This study will compare the patient-reported outcomes of telegenetics with in-person consultations for participants considering germline testing for HBOC or Lynch syndrome. It will clarify if telegenetics is a feasible and non-inferior alternative to in-person cancer genetic counselling. Participant responses are important stakeholder views to guide the design of telegenetics to become a mainstream service delivery model welcomed by patients. It aims to recruit 150 prospective consecutive patients attending genetic counselling for Hereditary Breast and Ovarian Cancer (HBOC) and Lynch Syndrome in Clinical Genetic Services (CGS) at National Cancer Centre Singapore (NCCS). Upon completion of the genetic consultation appointments, patients will be completing a series of questions evaluating cognitive and psychosocial outcomes either via hardcopy in-person or online internet-facing questionnaire.

Conditions

• Genetic Counselling

Interventions

Type	Name	Description
OTHER	Patients referred to CGS at NCCS for HBOC or Lynch syndrome pre-test genetic counselling.	Patients are given a series of questions evaluating cognitive and psychosocial outcomes, either via hardcopy in-person or online internet-facing questionnaire.

Timeline

• Start date: 2021-02-01
• Primary completion: 2025-10-16
• Completion: 2025-10-16
• First posted: 2021-02-04
• Last updated: 2025-01-06

Locations

1 site across 1 country: Singapore